Genetic alterations driving metastatic colony formation are acquired outside of the primary tumour in melanoma.
Melanie Werner-KleinSebastian ScheitlerMartin HoffmannIsabelle HodakKlaus DietzPetra LehnertVeronika NaimerBernhard PolzerSteffi TreitschkeChristian WernoAleksandra MarkiewiczKathrin WeideleZbigniew CzyzUlrich HohenleutnerChristian HafnerSebastian HaferkampMark BerneburgPetra RümmeleAnja UlmerChristoph A KleinPublished in: Nature communications (2018)
Mouse models indicate that metastatic dissemination occurs extremely early; however, the timing in human cancers is unknown. We therefore determined the time point of metastatic seeding relative to tumour thickness and genomic alterations in melanoma. Here, we find that lymphatic dissemination occurs shortly after dermal invasion of the primary lesion at a median thickness of ~0.5 mm and that typical driver changes, including BRAF mutation and gained or lost regions comprising genes like MET or CDKNA2, are acquired within the lymph node at the time of colony formation. These changes define a colonisation signature that was linked to xenograft formation in immunodeficient mice and death from melanoma. Thus, melanoma cells leave primary tumours early and evolve at different sites in parallel. We propose a model of metastatic melanoma dormancy, evolution and colonisation that will inform direct monitoring of adjuvant therapy targets.
Keyphrases
- lymph node
- squamous cell carcinoma
- small cell lung cancer
- endothelial cells
- optical coherence tomography
- genome wide
- mouse model
- skin cancer
- copy number
- neoadjuvant chemotherapy
- gene expression
- radiation therapy
- type diabetes
- dna methylation
- tyrosine kinase
- insulin resistance
- young adults
- cell migration
- metabolic syndrome
- bioinformatics analysis